In order to assess the inhibitory activities of YPC-21440 and YPC-21817 against Pim kinases in cells, we determined the phosphorylation levels of substrates of Pim kinases, Bad, 4EBP, and p21, in cancer cell lines treated with these compounds (Figure 3B). This evidence concerns the gene CDKN1A and cancer.